419 related articles for article (PubMed ID: 26510920)
1. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients.
Khatiwada S; Rajendra KC; Gautam S; Lamsal M; Baral N
BMC Endocr Disord; 2015 Oct; 15():65. PubMed ID: 26510920
[TBL] [Abstract][Full Text] [Related]
2. Thyroid dysfunction and its effect in serum lipids.
Shrestha N
J Nepal Health Res Counc; 2011 Apr; 9(1):33-7. PubMed ID: 22929710
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia and serum mineral profiles in patients with thyroid disorders.
Abdel-Gayoum AA
Saudi Med J; 2014 Dec; 35(12):1469-76. PubMed ID: 25491211
[TBL] [Abstract][Full Text] [Related]
4. Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults.
Gopinath B; Harris DC; Wall JR; Kifley A; Mitchell P
Maturitas; 2013 Jun; 75(2):159-64. PubMed ID: 23541904
[TBL] [Abstract][Full Text] [Related]
5. Relationship of metabolic syndrome and its components with thyroid dysfunction in Algerian patients.
Hamlaoui ML; Ayachi A; Dekaken A; Gouri A
Diabetes Metab Syndr; 2018; 12(1):1-4. PubMed ID: 28843650
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function and cardiovascular events in chronic kidney disease patients.
Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
[TBL] [Abstract][Full Text] [Related]
7. Circulating lipids and minor abnormalities of thyroid function.
Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1992 Nov; 37(5):411-4. PubMed ID: 1486690
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis.
Kotwal A; Cortes T; Genere N; Hamidi O; Jasim S; Newman CB; Prokop LJ; Murad MH; Alahdab F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32954428
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone profile in patients with chronic kidney disease: a single centre study.
Singh S; Verma A; Aryal G; Thapa S; Khakurel S; Shrestha K
J Nepal Health Res Counc; 2016 Sep; 14(34):197-201. PubMed ID: 28327686
[TBL] [Abstract][Full Text] [Related]
10. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study.
Schultheiss UT; Daya N; Grams ME; Seufert J; Steffes M; Coresh J; Selvin E; Köttgen A
Nephrol Dial Transplant; 2017 Nov; 32(11):1874-1881. PubMed ID: 27540046
[TBL] [Abstract][Full Text] [Related]
11. Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.
Dey R; Rajappa M; Parameswaran S; Revathy G
Clin Exp Nephrol; 2015 Dec; 19(6):1054-61. PubMed ID: 25697595
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study.
Nakano T; Tanaka S; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2021 Apr; 25(4):385-393. PubMed ID: 33398604
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone status in Ghanaian patients with chronic kidney disease.
Aryee NA; Tagoe EA; Anomah V; Arko-Boham B; Adjei DN
Pan Afr Med J; 2018; 29():137. PubMed ID: 30050601
[TBL] [Abstract][Full Text] [Related]
14. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
[TBL] [Abstract][Full Text] [Related]
15. Relationship of thyroid-stimulating hormone levels to development of dyslipidemia and determination of an ideal cut-off point to start replacement therapy.
Sarzosa Terán V; Astudillo Calle MA
Endocrinol Nutr; 2012 Dec; 59(10):575-82. PubMed ID: 23036934
[TBL] [Abstract][Full Text] [Related]
16. Serum lipid profile in patients with thyroid disorders in central Nepal.
Regmi A; Shah B; Rai BR; Pandeya A
Nepal Med Coll J; 2010 Dec; 12(4):253-6. PubMed ID: 21744769
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hypothyroidism in patients with dyslipidemia: Tehran Thyroid Study (TTS).
Khazan M; Amouzegar A; Gharibzadeh S; Mehran L; Tohidi M; Azizi F
Horm Metab Res; 2014 Dec; 46(13):980-4. PubMed ID: 25369072
[TBL] [Abstract][Full Text] [Related]
18. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.
Sangsawang T; Sriwijitkamol A
Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773
[TBL] [Abstract][Full Text] [Related]
19. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.
Jung CH; Sung KC; Shin HS; Rhee EJ; Lee WY; Kim BS; Kang JH; Kim H; Kim SW; Lee MH; Park JR; Kim SW
Korean J Intern Med; 2003 Sep; 18(3):146-53. PubMed ID: 14619383
[TBL] [Abstract][Full Text] [Related]
20. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans.
Kim CS; Kang JG; Lee SJ; Ihm SH; Yoo HJ; Nam JS; Ahn CW; Kim KR
Clin Endocrinol (Oxf); 2009 Jul; 71(1):130-6. PubMed ID: 19178521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
